InfuSystem reports Q3 earnings

Thursday, November 15, 2018

MADISON HEIGHTS, Mich. – InfuSystem Holdings reported net revenues of $16.7 million for the third quarter of 2018, a 5% decreased compared to the same quarter in 2017. Adjusted EBITDA was $3.3 million, a 15% decrease. “We are making strong progress and gaining traction on our strategic initiatives that we believe will lead to significant oncology market share gains in 2019,” said Richard Dilorio, CEO. “This includes the introduction during the third quarter of InfuSystem Mobile, a ‘first of its kind’ mobile application to enhance safety and communication.” For the nine months ended Sept. 30, 2018, the company reported net revenues of $49.6 million, a decrease of 5% for the same period in 2017.